Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NCT05327127 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH

Interventions

DRUG: K-877-ER
DRUG: CSG452
DRUG: Placebo

Sponsor

Kowa Research Institute, Inc.